Medable Enterprise Playbook

Welcome to the Medable Enterprise Playbook. Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development at scale.

Our digital trial platform replaces traditional siloed systems with a purpose-built enterprise platform providing the tools, data and interfaces to accelerate study timeline, enriching the patient experience during the trial to promote better patient enrolment and trial retention.

Medable's platform is accessible on any web-based device, which allows patients and their caregivers to safely and securely participate in clinical research from anywhere.

By seamlessly fitting into patient lives, Medable improves patient engagement and compliance while ensuring robust, high quality data capture with ability to monitor in real-time for safety and efficacy.

Medable’s software has been named a leader in the industry by both Everest Group and IDC.

Medable's modular solution allows partners to implement any combination of the following solutions, based on your unique protocol needs:

  • eConsent
  • Televisit
  • eCOA and eDiaries
  • Connected sensors
  • Integrations to other systems
  • Prescreening questionnaires

Patients, sites, and study teams can access these solutions through Medable's applications: Site App (Web), Patient App (iOS/Android, Web), and Study Manager (Web).

Playbook Sections

Navigate to the following Playbook sections for more information on partnership governance, standard study delivery processes, and partnership-specific processes.

Partnership Overview

Learn the fundamental approaches and best practices about partnership governance.

Study Delivery

Discover our detailed standard study delivery processes for achieve the best outcomes.

Appendix

Explore the details that are unique to our partnership with your company.

Reminder!

  • The Enterprise Playbook website is updated as our processes change.
  • This playbook is not a replacement for our current policies/procedures.
  • If you have any request, please contact your Portfolio Director.

Trusted by